简体中文
  http://www.jcps.ac.cn  
Home   |   About Journal   |   Editorial Board   |   For Authors   |   Subscriptions   |   Contacts Us
Journal of Chinese Pharmaceutical Sciences  2018, Vol. 27 Issue (1): 14-21    DOI: 10.5246/jcps.2018.01.002
Original articles Current Issue | Archive | Adv Search |
Influence of CYP2C9*2 genetic polymorphism on pharmacokinetics of losartan and its active metabolite E-3174 on the background of CYP3A4 wild genotype in healthy Chinese Hui subjects
Lu Yang1, Tao Guo2, Xuemei Zhuang3, Hongyan Gu1*
1. Department of Pharmacy, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing 100038, China
2. Department of Pharmacy, the General Hospital of Shenyang Military Region, Shenyang 110015, China
3. Department of Pharmacy, shandong energy zaozhuang mining group center hospital, Zaozhuang 277800, China
    PDF Preview
    
京ICP备05051953号-6
 Copyright © Journal of Chinese Pharmaceutical Sciences, School of  Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Support by
Beijing Magtech Co.ltd , E-mail: support@magtech.com.cn